Report Categories
View AllRecent Articles
View All
IKT Inhibikase Therapeutics beats Q4 2025 loss estimates shares post modest gains following earnings release
BST Blk SciTech leadership emphasizes highgrowth unlisted tech holdings as key longterm value driver
MAIN Main notches slight share gain after Q4 2025 earnings top consensus EPS estimates by 43 percent
AACOU Abony Acq I reports quiet quarter as SPAC continues acquisition search amid market uncertainty